PJ

Poonam Jha

Active Director Director DIN 07525108
DIN 07525108 First appointment May 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2016
Shareholding value •••• Premium profile

About Poonam Jha

Data last updated:

Poonam Jha is a Director at Olamiken Life Science Private Limited (since 2016). The company operates in Pharma. Olamiken Life Science Private Limited reported revenue of ₹64.2 Lakh (FY 2020).

DIN 07525108
Primary Designation Director
Industry Pharma
First Appointment 23 May 2016
Oldest Company Age 10 yrs
Largest company Olamiken Life Science Private Limited · ₹64.2 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 May 20162016₹64.2 Lakh (FY 2020)Active

Board colleagues of Poonam Jha

NameDINCompanyDesignation
Rakesh Kumar Jha07525107Olamiken Life Science Private LimitedDirector

Directorship timeline

Open interactive timeline →
Olamiken Life Science Private Limited
Premium access

Shareholding and investment profile for Poonam Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Poonam Jha

Poonam Jha currently holds 1 directorship: Olamiken Life Science Private Limited (Director, since 23 May 2016, revenue ₹64.2 Lakh (FY 2020)).

Poonam Jha was first appointed on 23 May 2016 as Director at Olamiken Life Science Private Limited.

The current boards of Poonam Jha's companies include Rakesh Kumar Jha (Olamiken Life Science Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available